Filing Details
- Accession Number:
- 0000950170-25-025914
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-24 19:04:25
- Reporting Period:
- 2025-02-21
- Filing Date:
- 2025-02-24
- Accepted Time:
- 2025-02-24 19:04:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1347178 | Vanda Pharmaceuticals Inc. | VNDA | Pharmaceutical Preparations (2834) | 030491827 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1806596 | Patrick Kevin Moran | 2200 Pennsylvania Avenue Nw Suite 300E Washington DC 20037 | Svp, Cfo & Treasurer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-02-21 | 2,000 | $4.39 | 355,763 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 635 | Indirect | By Wife |
Billionaire Hedge Funds
